Form 4: Thermo Fisher Scientific Director Karen S. Lynch Reports Stock Transactions
SEC Filing
Director Karen S. Lynch reports acquisition and disposal of Thermo Fisher Scientific Inc. common stock.
Summary
- Karen S. Lynch, a director of Thermo Fisher Scientific Inc., filed a Form 4 with the SEC.
- The report details changes in her beneficial ownership of the company's common stock.
- On February 19, 2025, she acquired 95 shares of common stock.
- On the same day, she disposed of 95 shares of common stock.
- She also indirectly owns 76 shares through a living trust.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't convey any particular positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders to report their transactions in company stock, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 02/19/2025 | Date of stock acquisition and disposal. |
| 02/21/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Thermo Fisher Scientific, Stock Transaction, Director, Lynch, TMO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.